BioSpace News Archive

Antipsychotics linked to accumulation of hospital days in persons with Alzheimer’s disease

People with Alzheimer’s disease who used antipsychotic drugs had a higher number of accumulated hospital days than people with Alzheimer’s disease who did not use antipsychotics, according to a new study from the University of Eastern Finland.

October 8, 2019
·
2 min read
Santhera Announces Presentation by ReveraGen of Positive 18-Month Data with Vamorolone in Duchenne Muscular Dystrophy

Santhera Pharmaceuticals announces presentation of data showing continued improvement of muscle function and improved tolerability compared with corticosteroids of 18-month vamorolone treatment in Duchenne muscular dystrophy.

October 8, 2019
·
7 min read
Business

Sensyne Health Maiden Full Year Results

Sensyne Health plc, the British Clinical AI technology company, announces its audited full year results for the 12 months ended 30 April 2019.

October 8, 2019
·
3 min read
Sensyne Health signs major agreements with a Fortune 200 healthcare company and a data infrastructure specialist to launch and scale its digital health products in the U.S.

Sensyne Health plc, the British clinical AI technology company, announced it has signed agreements with a Fortune 200 company and a data infrastructure specialist to launch and scale its digital health products under licence in the U.S.

October 8, 2019
·
3 min read
Deals

Sensyne Health: Annual Report and Accounts and Notice of Annual General Meeting

Sensyne Health plc, the British clinical AI technology company, announces that its Annual Report and Accounts for the year ended 30 April 2019 is now available on the Group’s website at www.sensynehealth.com/investors.

October 8, 2019
·
1 min read
Business

Sensyne Health enters into a research collaboration with UK MHRA to validate digital health software algorithms

Sensyne Health plc, the British clinical AI technology company, announced it has entered into a formal research agreement with the UK MHRA to contribute to the development of methods to validate software algorithms used in digital health.

October 8, 2019
·
1 min read
Policy

Biom’up announces the approval of HEMOBLASTTM Bellows and its laparoscopic applicator in Australia

Successful review of HEMOBLAST Bellows’ performance and safety profile as well as Biom’up’s Quality Management System by the Australian Therapeutic Goods Administration (TGA)

October 8, 2019
·
5 min read
Business

ProBioGen and Ceva Santé Animale Sign an Exclusive License Agreement to Produce Vectorised Poultry Vaccines Using AGE1.CR® Production Technology

ProBioGen AG and Ceva Santé Animale announce the signature of an exclusive license agreement for the manufacture of vectorised poultry vaccines using ProBioGen’s proprietary AGE1.CR® technology.

October 8, 2019
·
2 min read
Business

Sareum: Notice of FY 2019 Results

Sareum Holdings plc, the specialised small molecule drug development business, will announce its results for the full year ended 30 June 2019 on Tuesday 15 October.

October 8, 2019
·
2 min read
Pharm Country

Castor Announces International Expansion to Meet Growing Demand for AI-Powered Clinical Data Platform

Amsterdam, The Netherlands and Hoboken, New Jersey, USA, October 7, 2019: Castor, a health-tech company that helps medical researchers maximize the value of research data, announces its international business expansion.

October 8, 2019
·
3 min read